Lunate Capital’s Neumora Therapeutics NMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.56M Hold
2,124,143
0.87% 4
2025
Q1
$2.12M Buy
+2,124,143
New +$2.12M 1.24% 4